The global organoids and spheroids market size is expected to reach USD 3.26 billion by 2030, registering a CAGR of 23.11% during the forecast period, A rise in the adoption of organoid cultures in drug discovery, and rising demand for cell therapy and tissue engineering across the globe is expected to drive the market. ![Organoids And Spheroids Market]( "Organoids And Spheroids Market")
3D spheroids are considered as an important aspect of tissue engineering and regenerative medicine research as they can be used as building blocks for the generation of complex tissues and organs. In addition, the potential of 3D cell cultures to be used as models for drug screening and analysis of human disorders are expected to provide ample growth opportunities to the market in the near future.
A rise in the adoption of organoid cultures for the assessment of the mechanism of human-specific disorders is expected to enhance the market growth. For instance, human organoids have helped in the analysis of a wide range of tissues including the small intestine, prostate, brain, and liver. The promise of the generation of 3D cell cultures that resemble human organs has brought an enormous potential for the use of organoids as cell therapies, and as prospective substitutes for whole-organ transplantation.
3D spheroids are considered as an important aspect of tissue engineering and regenerative medicine research as they can be used as building blocks for the generation of complex tissues and organs. In addition, the potential of 3D cell cultures to be used as models for drug screening and analysis of human disorders are expected to provide ample growth opportunities to the market in the near future.
A rise in the adoption of organoid cultures for the assessment of the mechanism of human-specific disorders is expected to enhance the market growth. For instance, human organoids have helped in the analysis of a wide range of tissues including the small intestine, prostate, brain, and liver. The promise of the generation of 3D cell cultures that resemble human organs has brought an enormous potential for the use of organoids as cell therapies, and as prospective substitutes for whole-organ transplantation.
Organoids And Spheroids Market Report Highlights
- The spheroids segment is anticipated to dominate the market throughout the analysis period
- Higher adoption of 3D spheroids in the fields of drug discovery, disease modeling, and safety testing is a key factor driving the segment
- The developmental biology application segment accounted for the largest revenue share in 2023 as the development of organoids from Induced Pluripotent Stem Cells (iPSCs) have paved way for dynamic observation of cell development and propelled the adoption of mechanistic studies for human development
- Biotechnology and pharmaceutical industries dominated the end-use segment in the market in 2023. This is because of the high utilization rate of organoids and spheroids in pre-clinical drug discovery by pharma entities
- In addition, these players are actively involved in the development of advanced products that enhance the efficiency of organoid and spheroid generation.
- In North America, the market generated the highest revenue in 2023 due to higher adoption of technologically advanced cell culture platforms, and the presence of a large number of universities and academic institutions actively involved in cell and organ-based studies
- In addition, a higher adoption rate of organoid and spheroid culture products and efficient healthcare infrastructure in North America is attributive to the largest revenue generation from the region
- In Asia Pacific, the market is anticipated to witness lucrative growth over the forecast period.
- Presence of key players and government organizations such as STEMCELL Technologies, Australasian Society for Stem Cell Research (ASSCR), The Japanese Society for Regenerative Medicine, The Korean Society for Stem Cell Research (KSSCR), and others are expected to enhance the penetration of organoid and spheroid culture in Asia
- The key players are constantly involved in research and development of new products so that they can enhance their market position
Table of Contents
Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Type
1.1.2. Application
1.1.3. End-Use
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. Internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.6.1. Commodity flow analysis
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
1.1.1. Type
1.1.2. Application
1.1.3. End-Use
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. Internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.6.1. Commodity flow analysis
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. Organoids & Spheroids Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. High adoption of organoids & spheroids in drug discovery
3.2.1.2. Technological advancements
3.2.1.3. Rising demand for tissue engineering & organ transplantation
3.2.2. Market restraint analysis
3.2.2.1. Challenges associated with 3D cell culturing
3.2.2.2. Ethical issues associated with organoid & spheroid cultures
3.3. Organoids & Spheroids Market Analysis Tools
3.3.1. Porter’s Five Forces Analysis
3.3.2. PESTEL Analysis
3.3.3. COVID-19 Impact Analysis
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. High adoption of organoids & spheroids in drug discovery
3.2.1.2. Technological advancements
3.2.1.3. Rising demand for tissue engineering & organ transplantation
3.2.2. Market restraint analysis
3.2.2.1. Challenges associated with 3D cell culturing
3.2.2.2. Ethical issues associated with organoid & spheroid cultures
3.3. Organoids & Spheroids Market Analysis Tools
3.3.1. Porter’s Five Forces Analysis
3.3.2. PESTEL Analysis
3.3.3. COVID-19 Impact Analysis
Chapter 4. Type Business Analysis
4.1. Segment Dashboard
4.2. Global Organoids & Spheroids Market: Type Movement Analysis
4.3. Global Organoids & Spheroids Market Size & Trend Analysis, by Type, 2018 to 2030 (USD Million)
4.4. Organoids
4.4.1. Organoids market estimates and forecast, 2018 - 2030
4.4.2. Organoids by Type
4.4.2.1. Neural Organoids
4.4.2.1.1. Neural organoids market estimates and forecast, 2018 - 2030
4.4.2.2. Hepatic Organoids
4.4.2.2.1. Hepatic organoids market estimates and forecast, 2018 - 2030
4.4.2.3. Intestinal organoids
4.4.2.3.1. Intestinal organoids market estimates and forecast, 2018 - 2030
4.4.2.4. Other organoids
4.4.2.4.1. Other organoids market estimates and forecast, 2018 - 2030
4.4.3. Organoids by Method
4.4.3.1. General Submerged Method for Organoid Culture
4.4.3.1.1. General Submerged Method for Organoid Culture market estimates and forecast, 2018 - 2030
4.4.3.2. Crypt Organoid Culture Techniques
4.4.3.2.1. Crypt Organoid Culture Techniques market estimates and forecast, 2018 - 2030
4.4.3.3. Air Liquid Interface (ALI) Method for Organoid Culture
4.4.3.3.1. ALI Method for Organoid Culture market estimates and forecast, 2018 - 2030
4.4.3.4. Clonal Organoids from Lgr5+ Cells
4.4.3.4.1. Clonal Organoids from Lgr5+ Cells market estimates and forecast, 2018 - 2030
4.4.3.5. Brain and Retina Organoid Formation Protocol
4.4.3.5.1. Brain and Retina Organoid Formation Protocol market estimates and forecast, 2018 - 2030
4.4.3.6. Others
4.4.3.6.1. Others market estimates and forecast, 2018 - 2030
4.4.4. Organoids by Source
4.4.4.1. Primary Tissues
4.4.4.1.1. Primary tissues market estimates and forecast, 2018 - 2030
4.4.4.2. Stem Cells
4.4.4.2.1. Stem cells market estimates and forecast, 2018 - 2030
4.5. Spheroids
4.5.1. Spheroids market estimates and forecast, 2018 - 2030
4.5.2. Spheroids by Type
4.5.2.1. Multicellular tumor spheroids (MCTS)
4.5.2.1.1. MCTS market estimates and forecast, 2018 - 2030
4.5.2.2. Neurospheres
4.5.2.2.1. Neurospheres market estimates and forecast, 2018 - 2030
4.5.2.3. Mammospheres
4.5.2.3.1. Mammospheres market estimates and forecast, 2018 - 2030
4.5.2.4. Hepatospheres
4.5.2.4.1. Hepatospheres market estimates and forecast, 2018 - 2030
4.5.2.5. Embryoid bodies
4.5.2.5.1. Embryoid bodies market estimates and forecast, 2018 - 2030
4.5.3. Spheroids by Method
4.5.3.1. Micropatterned Plates
4.5.3.1.1. Micropatterned Plates market estimates and forecast, 2018 - 2030
4.5.3.2. Low Cell Attachment Plates
4.5.3.2.1. Low Cell Attachment Plates market estimates and forecast, 2018 - 2030
4.5.3.3. Hanging Drop Method
4.5.3.3.1. Hanging Drop Method for spheroid Culture market estimates and forecast, 2018 - 2030
4.5.3.4. Others
4.5.3.4.1. Other methods for spheroid culture market estimates and forecast, 2018 - 2030
4.5.4. Spheroids by Source
4.5.4.1. Cell Line
4.5.4.1.1. Cell line market estimates and forecast, 2018 - 2030
4.5.4.2. Primary Cell
4.5.4.2.1. Primary cell market estimates and forecast, 2018 - 2030
4.5.4.3. iPSCs Derived Cells
4.5.4.3.1. iPSCs Derived Cells market estimates and forecast, 2018 - 2030
4.2. Global Organoids & Spheroids Market: Type Movement Analysis
4.3. Global Organoids & Spheroids Market Size & Trend Analysis, by Type, 2018 to 2030 (USD Million)
4.4. Organoids
4.4.1. Organoids market estimates and forecast, 2018 - 2030
4.4.2. Organoids by Type
4.4.2.1. Neural Organoids
4.4.2.1.1. Neural organoids market estimates and forecast, 2018 - 2030
4.4.2.2. Hepatic Organoids
4.4.2.2.1. Hepatic organoids market estimates and forecast, 2018 - 2030
4.4.2.3. Intestinal organoids
4.4.2.3.1. Intestinal organoids market estimates and forecast, 2018 - 2030
4.4.2.4. Other organoids
4.4.2.4.1. Other organoids market estimates and forecast, 2018 - 2030
4.4.3. Organoids by Method
4.4.3.1. General Submerged Method for Organoid Culture
4.4.3.1.1. General Submerged Method for Organoid Culture market estimates and forecast, 2018 - 2030
4.4.3.2. Crypt Organoid Culture Techniques
4.4.3.2.1. Crypt Organoid Culture Techniques market estimates and forecast, 2018 - 2030
4.4.3.3. Air Liquid Interface (ALI) Method for Organoid Culture
4.4.3.3.1. ALI Method for Organoid Culture market estimates and forecast, 2018 - 2030
4.4.3.4. Clonal Organoids from Lgr5+ Cells
4.4.3.4.1. Clonal Organoids from Lgr5+ Cells market estimates and forecast, 2018 - 2030
4.4.3.5. Brain and Retina Organoid Formation Protocol
4.4.3.5.1. Brain and Retina Organoid Formation Protocol market estimates and forecast, 2018 - 2030
4.4.3.6. Others
4.4.3.6.1. Others market estimates and forecast, 2018 - 2030
4.4.4. Organoids by Source
4.4.4.1. Primary Tissues
4.4.4.1.1. Primary tissues market estimates and forecast, 2018 - 2030
4.4.4.2. Stem Cells
4.4.4.2.1. Stem cells market estimates and forecast, 2018 - 2030
4.5. Spheroids
4.5.1. Spheroids market estimates and forecast, 2018 - 2030
4.5.2. Spheroids by Type
4.5.2.1. Multicellular tumor spheroids (MCTS)
4.5.2.1.1. MCTS market estimates and forecast, 2018 - 2030
4.5.2.2. Neurospheres
4.5.2.2.1. Neurospheres market estimates and forecast, 2018 - 2030
4.5.2.3. Mammospheres
4.5.2.3.1. Mammospheres market estimates and forecast, 2018 - 2030
4.5.2.4. Hepatospheres
4.5.2.4.1. Hepatospheres market estimates and forecast, 2018 - 2030
4.5.2.5. Embryoid bodies
4.5.2.5.1. Embryoid bodies market estimates and forecast, 2018 - 2030
4.5.3. Spheroids by Method
4.5.3.1. Micropatterned Plates
4.5.3.1.1. Micropatterned Plates market estimates and forecast, 2018 - 2030
4.5.3.2. Low Cell Attachment Plates
4.5.3.2.1. Low Cell Attachment Plates market estimates and forecast, 2018 - 2030
4.5.3.3. Hanging Drop Method
4.5.3.3.1. Hanging Drop Method for spheroid Culture market estimates and forecast, 2018 - 2030
4.5.3.4. Others
4.5.3.4.1. Other methods for spheroid culture market estimates and forecast, 2018 - 2030
4.5.4. Spheroids by Source
4.5.4.1. Cell Line
4.5.4.1.1. Cell line market estimates and forecast, 2018 - 2030
4.5.4.2. Primary Cell
4.5.4.2.1. Primary cell market estimates and forecast, 2018 - 2030
4.5.4.3. iPSCs Derived Cells
4.5.4.3.1. iPSCs Derived Cells market estimates and forecast, 2018 - 2030
Chapter 5. End-Use Business Analysis
5.1. Segment Dashboard
5.2. Global Organoids & Spheroids Market: End Use Movement Analysis
5.3. Global Organoids & Spheroids Market Size & Trend Analysis, by End-use, 2018 to 2030 (USD Million)
5.4. Biotechnology and Pharmaceutical Industries
5.4.1. Biotechnology and Pharmaceutical Industries market estimates and forecast 2018 to 2030 (USD million)
5.5. Academic & Research Institutes
5.5.1. Academic & Research Institutes market estimates and forecast 2018 to 2030 (USD Million)
5.6. Hospitals and Diagnostic Centers
5.6.1. Hospitals and Diagnostic Centers market estimates and forecast 2018 to 2030 (USD million)
5.2. Global Organoids & Spheroids Market: End Use Movement Analysis
5.3. Global Organoids & Spheroids Market Size & Trend Analysis, by End-use, 2018 to 2030 (USD Million)
5.4. Biotechnology and Pharmaceutical Industries
5.4.1. Biotechnology and Pharmaceutical Industries market estimates and forecast 2018 to 2030 (USD million)
5.5. Academic & Research Institutes
5.5.1. Academic & Research Institutes market estimates and forecast 2018 to 2030 (USD Million)
5.6. Hospitals and Diagnostic Centers
5.6.1. Hospitals and Diagnostic Centers market estimates and forecast 2018 to 2030 (USD million)
Chapter 6. Application Business Analysis
6.1. Segment Dashboard
6.2. Global Organoids & Spheroids Market: Application Movement Analysis
6.3. Global Organoids & Spheroids Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
6.4. Developmental Biology
6.4.1. Developmental Biology market estimates and forecast 2018 to 2030 (USD million)
6.5. Personalized Medicine
6.5.1. Personalized Medicine market estimates and forecast 2018 to 2030 (USD Million)
6.6. Regenerative Medicine
6.6.1. Regenerative Medicine market estimates and forecast 2018 to 2030 (USD million)
6.7. Disease Pathology Studies
6.7.1. Disease Pathology Studies market estimates and forecast 2018 to 2030 (USD Million)
6.8. Drug Toxicity & Efficacy Testing
6.8.1. Drug Toxicity & Efficacy Testing market estimates and forecast 2018 to 2030 (USD Million)
6.2. Global Organoids & Spheroids Market: Application Movement Analysis
6.3. Global Organoids & Spheroids Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
6.4. Developmental Biology
6.4.1. Developmental Biology market estimates and forecast 2018 to 2030 (USD million)
6.5. Personalized Medicine
6.5.1. Personalized Medicine market estimates and forecast 2018 to 2030 (USD Million)
6.6. Regenerative Medicine
6.6.1. Regenerative Medicine market estimates and forecast 2018 to 2030 (USD million)
6.7. Disease Pathology Studies
6.7.1. Disease Pathology Studies market estimates and forecast 2018 to 2030 (USD Million)
6.8. Drug Toxicity & Efficacy Testing
6.8.1. Drug Toxicity & Efficacy Testing market estimates and forecast 2018 to 2030 (USD Million)
Chapter 7. Regional Business Analysis, by Country, Type, Application, & End-use
7.1. Segment Dashboard
7.2. Market Size & Forecasts and Trend Analysis, 2018 to 2030
7.3. North America
7.3.1. North America Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
7.3.2. U.S.
7.3.2.1. Key Country Dynamics
7.3.2.2. Target Disease Prevalence
7.3.2.3. Competitive Scenario
7.3.2.4. U.S. Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
7.3.3. Canada
7.3.3.1. Key Country Dynamics
7.3.3.2. Target Disease Prevalence
7.3.3.3. Competitive Scenario
7.3.3.4. Canada Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
7.4. Europe
7.4.1. Europe Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
7.4.2. UK
7.4.2.1. Key Country Dynamics
7.4.2.2. Target Disease Prevalence
7.4.2.3. Competitive Scenario
7.4.2.4. UK Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
7.4.3. Germany
7.4.3.1. Key Country Dynamics
7.4.3.2. Target Disease Prevalence
7.4.3.3. Competitive Scenario
7.4.3.4. Germany Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
7.4.4. France
7.4.4.1. Key Country Dynamics
7.4.4.2. Target Disease Prevalence
7.4.4.3. Competitive Scenario
7.4.4.4. France Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
7.4.5. Italy
7.4.5.1. Key Country Dynamics
7.4.5.2. Target Disease Prevalence
7.4.5.3. Competitive Scenario
7.4.5.4. Italy Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
7.4.6. Spain
7.4.6.1. Key Country Dynamics
7.4.6.2. Target Disease Prevalence
7.4.6.3. Competitive Scenario
7.4.6.4. Spain Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
7.4.7. Denmark
7.4.7.1. Key Country Dynamics
7.4.7.2. Target Disease Prevalence
7.4.7.3. Competitive Scenario
7.4.7.4. Denmark Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
7.4.8. Sweden
7.4.8.1. Key Country Dynamics
7.4.8.2. Target Disease Prevalence
7.4.8.3. Competitive Scenario
7.4.8.4. Sweden Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
7.4.9. Norway
7.4.9.1. Key Country Dynamics
7.4.9.2. Target Disease Prevalence
7.4.9.3. Competitive Scenario
7.4.9.4. Norway Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
7.5. Asia Pacific
7.5.1. Asia Pacific Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
7.5.2. China
7.5.2.1. Key Country Dynamics
7.5.2.2. Target Disease Prevalence
7.5.2.3. Competitive Scenario
7.5.2.4. China Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
7.5.3. Japan
7.5.3.1. Key Country Dynamics
7.5.3.2. Target Disease Prevalence
7.5.3.3. Competitive Scenario
7.5.3.4. Japan Market estimates and forecast, 2018 - 2030 (Volume, Thousand)
7.5.4. India
7.5.4.1. Key Country Dynamics
7.5.4.2. Target Disease Prevalence
7.5.4.3. Competitive Scenario
7.5.4.4. India Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
7.5.5. Australia
7.5.5.1. Key Country Dynamics
7.5.5.2. Target Disease Prevalence
7.5.5.3. Competitive Scenario
7.5.5.4. Australia Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
7.5.6. Thailand
7.5.6.1. Key Country Dynamics
7.5.6.2. Target Disease Prevalence
7.5.6.3. Competitive Scenario
7.5.6.4. Thailand Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
7.5.7. South Korea
7.5.7.1. Key Country Dynamics
7.5.7.2. Target Disease Prevalence
7.5.7.3. Competitive Scenario
7.5.7.4. South Korea Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
7.6. Latin America
7.6.1. Latin America Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
7.6.2. Brazil
7.6.2.1. Key Country Dynamics
7.6.2.2. Target Disease Prevalence
7.6.2.3. Competitive Scenario
7.6.2.4. Brazil Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
7.6.3. Mexico
7.6.3.1. Key Country Dynamics
7.6.3.2. Target Disease Prevalence
7.6.3.3. Competitive Scenario
7.6.3.4. Mexico Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
7.6.4. Argentina
7.6.4.1. Key Country Dynamics
7.6.4.2. Target Disease Prevalence
7.6.4.3. Competitive Scenario
7.6.4.4. Argentina Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
7.7. MEA
7.7.1. MEA Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
7.7.2. Saudi Arabia
7.7.2.1. Key Country Dynamics
7.7.2.2. Target Disease Prevalence
7.7.2.3. Competitive Scenario
7.7.2.4. Saudi Arabia Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
7.7.3. South Africa
7.7.3.1. Key Country Dynamics
7.7.3.2. Target Disease Prevalence
7.7.3.3. Competitive Scenario
7.7.3.4. South Africa Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
7.7.4. UAE
7.7.4.1. Key Country Dynamics
7.7.4.2. Target Disease Prevalence
7.7.4.3. Competitive Scenario
7.7.4.4. UAE Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
7.7.5. Kuwait
7.7.5.1. Key Country Dynamics
7.7.5.2. Target Disease Prevalence
7.7.5.3. Competitive Scenario
7.7.5.4. Kuwait Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
7.2. Market Size & Forecasts and Trend Analysis, 2018 to 2030
7.3. North America
7.3.1. North America Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
7.3.2. U.S.
7.3.2.1. Key Country Dynamics
7.3.2.2. Target Disease Prevalence
7.3.2.3. Competitive Scenario
7.3.2.4. U.S. Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
7.3.3. Canada
7.3.3.1. Key Country Dynamics
7.3.3.2. Target Disease Prevalence
7.3.3.3. Competitive Scenario
7.3.3.4. Canada Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
7.4. Europe
7.4.1. Europe Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
7.4.2. UK
7.4.2.1. Key Country Dynamics
7.4.2.2. Target Disease Prevalence
7.4.2.3. Competitive Scenario
7.4.2.4. UK Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
7.4.3. Germany
7.4.3.1. Key Country Dynamics
7.4.3.2. Target Disease Prevalence
7.4.3.3. Competitive Scenario
7.4.3.4. Germany Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
7.4.4. France
7.4.4.1. Key Country Dynamics
7.4.4.2. Target Disease Prevalence
7.4.4.3. Competitive Scenario
7.4.4.4. France Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
7.4.5. Italy
7.4.5.1. Key Country Dynamics
7.4.5.2. Target Disease Prevalence
7.4.5.3. Competitive Scenario
7.4.5.4. Italy Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
7.4.6. Spain
7.4.6.1. Key Country Dynamics
7.4.6.2. Target Disease Prevalence
7.4.6.3. Competitive Scenario
7.4.6.4. Spain Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
7.4.7. Denmark
7.4.7.1. Key Country Dynamics
7.4.7.2. Target Disease Prevalence
7.4.7.3. Competitive Scenario
7.4.7.4. Denmark Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
7.4.8. Sweden
7.4.8.1. Key Country Dynamics
7.4.8.2. Target Disease Prevalence
7.4.8.3. Competitive Scenario
7.4.8.4. Sweden Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
7.4.9. Norway
7.4.9.1. Key Country Dynamics
7.4.9.2. Target Disease Prevalence
7.4.9.3. Competitive Scenario
7.4.9.4. Norway Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
7.5. Asia Pacific
7.5.1. Asia Pacific Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
7.5.2. China
7.5.2.1. Key Country Dynamics
7.5.2.2. Target Disease Prevalence
7.5.2.3. Competitive Scenario
7.5.2.4. China Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
7.5.3. Japan
7.5.3.1. Key Country Dynamics
7.5.3.2. Target Disease Prevalence
7.5.3.3. Competitive Scenario
7.5.3.4. Japan Market estimates and forecast, 2018 - 2030 (Volume, Thousand)
7.5.4. India
7.5.4.1. Key Country Dynamics
7.5.4.2. Target Disease Prevalence
7.5.4.3. Competitive Scenario
7.5.4.4. India Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
7.5.5. Australia
7.5.5.1. Key Country Dynamics
7.5.5.2. Target Disease Prevalence
7.5.5.3. Competitive Scenario
7.5.5.4. Australia Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
7.5.6. Thailand
7.5.6.1. Key Country Dynamics
7.5.6.2. Target Disease Prevalence
7.5.6.3. Competitive Scenario
7.5.6.4. Thailand Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
7.5.7. South Korea
7.5.7.1. Key Country Dynamics
7.5.7.2. Target Disease Prevalence
7.5.7.3. Competitive Scenario
7.5.7.4. South Korea Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
7.6. Latin America
7.6.1. Latin America Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
7.6.2. Brazil
7.6.2.1. Key Country Dynamics
7.6.2.2. Target Disease Prevalence
7.6.2.3. Competitive Scenario
7.6.2.4. Brazil Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
7.6.3. Mexico
7.6.3.1. Key Country Dynamics
7.6.3.2. Target Disease Prevalence
7.6.3.3. Competitive Scenario
7.6.3.4. Mexico Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
7.6.4. Argentina
7.6.4.1. Key Country Dynamics
7.6.4.2. Target Disease Prevalence
7.6.4.3. Competitive Scenario
7.6.4.4. Argentina Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
7.7. MEA
7.7.1. MEA Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
7.7.2. Saudi Arabia
7.7.2.1. Key Country Dynamics
7.7.2.2. Target Disease Prevalence
7.7.2.3. Competitive Scenario
7.7.2.4. Saudi Arabia Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
7.7.3. South Africa
7.7.3.1. Key Country Dynamics
7.7.3.2. Target Disease Prevalence
7.7.3.3. Competitive Scenario
7.7.3.4. South Africa Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
7.7.4. UAE
7.7.4.1. Key Country Dynamics
7.7.4.2. Target Disease Prevalence
7.7.4.3. Competitive Scenario
7.7.4.4. UAE Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
7.7.5. Kuwait
7.7.5.1. Key Country Dynamics
7.7.5.2. Target Disease Prevalence
7.7.5.3. Competitive Scenario
7.7.5.4. Kuwait Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
Chapter 8. Competitive Landscape
8.1. Company Categorization
8.2. Strategy Mapping
8.3. Company Market Position Analysis, 2023
8.4. Company Profiles/Listing
8.4.1. Thermo Fisher Scientific, Inc.
8.4.1.1. Company overview
8.4.1.2. Financial performance
8.4.1.3. Product benchmarking
8.4.1.4. Strategic initiatives
8.4.2. Merck KGaA
8.4.2.1. Company overview
8.4.2.2. Financial performance
8.4.2.3. Product benchmarking
8.4.2.4. Strategic initiatives
8.4.3. Lonza
8.4.3.1. Company overview
8.4.3.2. Financial performance
8.4.3.3. Product benchmarking
8.4.3.4. Strategic initiatives
8.4.4. 3D Biomatrix
8.4.4.1. Company overview
8.4.4.2. Financial performance
8.4.4.3. Product benchmarking
8.4.4.4. Strategic initiatives
8.4.5. 3D Biotek LLC
8.4.5.1. Company overview
8.4.5.2. Financial performance
8.4.5.3. Product benchmarking
8.4.5.4. Strategic initiatives
8.4.6. AMS Biotechnology (Europe) Limited
8.4.6.1. Company overview
8.4.6.2. Financial performance
8.4.6.3. Product benchmarking
8.4.6.4. Strategic initiatives
8.4.7. Cellesce Ltd
8.4.7.1. Company overview
8.4.7.2. Financial performance
8.4.7.3. Product benchmarking
8.4.7.4. Strategic initiatives
8.4.8. Corning Incorporated
8.4.8.1. Company overview
8.4.8.2. Financial performance
8.4.8.3. Product benchmarking
8.4.8.4. Strategic initiatives
8.4.9. Greiner Bio-One
8.4.9.1. Company overview
8.4.9.2. Financial performance
8.4.9.3. Product benchmarking
8.4.9.4. Strategic initiatives
8.4.10. Hubrecht Organoid Technology (HUB)
8.4.10.1. Company overview
8.4.10.2. Financial performance
8.4.10.3. Product benchmarking
8.4.10.4. Strategic initiatives
8.4.11. InSphero
8.4.11.1. Company overview
8.4.11.2. Financial performance
8.4.11.3. Product benchmarking
8.4.11.4. Strategic initiatives
8.4.12. Prellis Biologics
8.4.12.1. Company overview
8.4.12.2. Financial performance
8.4.12.3. Product benchmarking
8.4.12.4. Strategic initiatives
8.4.13. STEMCELL Technologies Inc.
8.4.13.1. Company overview
8.4.13.2. Financial performance
8.4.13.3. Product benchmarking
8.4.13.4. Strategic initiatives
8.2. Strategy Mapping
8.3. Company Market Position Analysis, 2023
8.4. Company Profiles/Listing
8.4.1. Thermo Fisher Scientific, Inc.
8.4.1.1. Company overview
8.4.1.2. Financial performance
8.4.1.3. Product benchmarking
8.4.1.4. Strategic initiatives
8.4.2. Merck KGaA
8.4.2.1. Company overview
8.4.2.2. Financial performance
8.4.2.3. Product benchmarking
8.4.2.4. Strategic initiatives
8.4.3. Lonza
8.4.3.1. Company overview
8.4.3.2. Financial performance
8.4.3.3. Product benchmarking
8.4.3.4. Strategic initiatives
8.4.4. 3D Biomatrix
8.4.4.1. Company overview
8.4.4.2. Financial performance
8.4.4.3. Product benchmarking
8.4.4.4. Strategic initiatives
8.4.5. 3D Biotek LLC
8.4.5.1. Company overview
8.4.5.2. Financial performance
8.4.5.3. Product benchmarking
8.4.5.4. Strategic initiatives
8.4.6. AMS Biotechnology (Europe) Limited
8.4.6.1. Company overview
8.4.6.2. Financial performance
8.4.6.3. Product benchmarking
8.4.6.4. Strategic initiatives
8.4.7. Cellesce Ltd
8.4.7.1. Company overview
8.4.7.2. Financial performance
8.4.7.3. Product benchmarking
8.4.7.4. Strategic initiatives
8.4.8. Corning Incorporated
8.4.8.1. Company overview
8.4.8.2. Financial performance
8.4.8.3. Product benchmarking
8.4.8.4. Strategic initiatives
8.4.9. Greiner Bio-One
8.4.9.1. Company overview
8.4.9.2. Financial performance
8.4.9.3. Product benchmarking
8.4.9.4. Strategic initiatives
8.4.10. Hubrecht Organoid Technology (HUB)
8.4.10.1. Company overview
8.4.10.2. Financial performance
8.4.10.3. Product benchmarking
8.4.10.4. Strategic initiatives
8.4.11. InSphero
8.4.11.1. Company overview
8.4.11.2. Financial performance
8.4.11.3. Product benchmarking
8.4.11.4. Strategic initiatives
8.4.12. Prellis Biologics
8.4.12.1. Company overview
8.4.12.2. Financial performance
8.4.12.3. Product benchmarking
8.4.12.4. Strategic initiatives
8.4.13. STEMCELL Technologies Inc.
8.4.13.1. Company overview
8.4.13.2. Financial performance
8.4.13.3. Product benchmarking
8.4.13.4. Strategic initiatives
List of Tables
Table 1 List of Abbreviations
Table 2 North America organoids and spheroids market, by type, 2018 - 2030 (USD Million)
Table 3 North America organoids and spheroids market, by end-use, 2018 - 2030 (USD Million)
Table 4 North America organoids and spheroids market, by application, 2018 - 2030 (USD Million)
Table 5 North America organoids and spheroids market, by region, 2018 - 2030 (USD Million)
Table 6 U.S. organoids and spheroids market, by type, 2018 - 2030 (USD Million)
Table 7 U.S. organoids and spheroids market, by end-use, 2018 - 2030 (USD Million)
Table 8 U.S. organoids and spheroids market, by application, 2018 - 2030 (USD Million)
Table 9 Canada organoids and spheroids market, by type, 2018 - 2030 (USD Million)
Table 10 Canada organoids and spheroids market, by end-use, 2018 - 2030 (USD Million)
Table 11 Canada organoids and spheroids market, by application, 2018 - 2030 (USD Million)
Table 12 Europe organoids and spheroids market, by type, 2018 - 2030 (USD Million)
Table 13 Europe organoids and spheroids market, by end-use, 2018 - 2030 (USD Million)
Table 14 Europe organoids and spheroids market, by application, 2018 - 2030 (USD Million)
Table 15 Europe organoids and spheroids market, by region, 2018 - 2030 (USD Million)
Table 16 Germany organoids and spheroids market, by type, 2018 - 2030 (USD Million)
Table 17 Germany organoids and spheroids market, by end-use, 2018 - 2030 (USD Million)
Table 18 Germany organoids and spheroids market, by application, 2018 - 2030 (USD Million)
Table 19 UK organoids and spheroids market, by type, 2018 - 2030 (USD Million)
Table 20 UK organoids and spheroids market, by end-use, 2018 - 2030 (USD Million)
Table 21 UK organoids and spheroids market, by application, 2018 - 2030 (USD Million)
Table 22 France organoids and spheroids market, by type, 2018 - 2030 (USD Million)
Table 23 France organoids and spheroids market, by end-use, 2018 - 2030 (USD Million)
Table 24 France organoids and spheroids market, by application, 2018 - 2030 (USD Million)
Table 25 Italy organoids and spheroids market, by type, 2018 - 2030 (USD Million)
Table 26 Italy organoids and spheroids market, by end-use, 2018 - 2030 (USD Million)
Table 27 Italy organoids and spheroids market, by application, 2018 - 2030 (USD Million)
Table 28 Spain organoids and spheroids market, by type, 2018 - 2030 (USD Million)
Table 29 Spain organoids and spheroids market, by end-use, 2018 - 2030 (USD Million)
Table 30 Spain organoids and spheroids market, by application, 2018 - 2030 (USD Million)
Table 31 Sweden organoids and spheroids market, by type, 2018 - 2030 (USD Million)
Table 32 Sweden organoids and spheroids market, by end-use, 2018 - 2030 (USD Million)
Table 33 Sweden organoids and spheroids market, by application, 2018 - 2030 (USD Million)
Table 34 Norway organoids and spheroids market, by type, 2018 - 2030 (USD Million)
Table 35 Norway organoids and spheroids market, by end-use, 2018 - 2030 (USD Million)
Table 36 Norway organoids and spheroids market, by application, 2018 - 2030 (USD Million)
Table 37 Denmark organoids and spheroids market, by type, 2018 - 2030 (USD Million)
Table 38 Denmark organoids and spheroids market, by end-use, 2018 - 2030 (USD Million)
Table 39 Denmark organoids and spheroids market, by application, 2018 - 2030 (USD Million)
Table 40 APAC organoids and spheroids market, by type, 2018 - 2030 (USD Million)
Table 41 APAC organoids and spheroids market, by end-use, 2018 - 2030 (USD Million)
Table 42 APAC organoids and spheroids market, by application, 2018 - 2030 (USD Million)
Table 43 APAC organoids and spheroids market, by region, 2018 - 2030 (USD Million)
Table 44 China organoids and spheroids market, by type, 2018 - 2030 (USD Million)
Table 45 China organoids and spheroids market, by end-use, 2018 - 2030 (USD Million)
Table 46 China organoids and spheroids market, by application, 2018 - 2030 (USD Million)
Table 47 Japan organoids and spheroids market, by type, 2018 - 2030 (USD Million)
Table 48 Japan organoids and spheroids market, by end-use, 2018 - 2030 (USD Million)
Table 49 Japan organoids and spheroids market, by application, 2018 - 2030 (USD Million)
Table 50 India organoids and spheroids market, by type, 2018 - 2030 (USD Million)
Table 51 India organoids and spheroids market, by end-use, 2018 - 2030 (USD Million)
Table 52 India organoids and spheroids market, by application, 2018 - 2030 (USD Million)
Table 53 Thailand organoids and spheroids market, by type, 2018 - 2030 (USD Million)
Table 54 Thailand organoids and spheroids market, by end-use, 2018 - 2030 (USD Million)
Table 55 Thailand organoids and spheroids market, by application, 2018 - 2030 (USD Million)
Table 56 South Korea organoids and spheroids market, by type, 2018 - 2030 (USD Million)
Table 57 South Korea organoids and spheroids market, by end-use, 2018 - 2030 (USD Million)
Table 58 South Korea organoids and spheroids market, by application, 2018 - 2030 (USD Million)
Table 59 Australia organoids and spheroids market, by type, 2018 - 2030 (USD Million)
Table 60 Australia organoids and spheroids market, by end-use, 2018 - 2030 (USD Million)
Table 61 Australia organoids and spheroids market, by application, 2018 - 2030 (USD Million)
Table 62 Latin America organoids and spheroids market, by type, 2018 - 2030 (USD Million)
Table 63 Latin America organoids and spheroids market, by end-use, 2018 - 2030 (USD Million)
Table 64 Latin America organoids and spheroids market, by application, 2018 - 2030 (USD Million)
Table 65 Latin America organoids and spheroids market, by region, 2018 - 2030 (USD Million)
Table 66 Brazil organoids and spheroids market, by type, 2018 - 2030 (USD Million)
Table 67 Brazil organoids and spheroids market, by end-use, 2018 - 2030 (USD Million)
Table 68 Brazil organoids and spheroids market, by application, 2018 - 2030 (USD Million)
Table 69 Mexico organoids and spheroids market, by type, 2018 - 2030 (USD Million)
Table 70 Mexico organoids and spheroids market, by end-use, 2018 - 2030 (USD Million)
Table 71 Mexico organoids and spheroids market, by application, 2018 - 2030 (USD Million)
Table 72 Argentina organoids and spheroids market, by type, 2018 - 2030 (USD Million)
Table 73 Argentina organoids and spheroids market, by end-use, 2018 - 2030 (USD Million)
Table 74 Argentina organoids and spheroids market, by application, 2018 - 2030 (USD Million)
Table 75 Middle East and Africa organoids and spheroids market, by type, 2018 - 2030 (USD Million)
Table 76 Middle East and Africa organoids and spheroids market, by end-use, 2018 - 2030 (USD Million)
Table 77 Middle East and Africa organoids and spheroids market, by application, 2018 - 2030 (USD Million)
Table 78 Middle East and Africa organoids and spheroids market, by region, 2018 - 2030 (USD Million)
Table 79 South Africa organoids and spheroids market, by type, 2018 - 2030 (USD Million)
Table 80 South Africa organoids and spheroids market, by end-use, 2018 - 2030 (USD Million)
Table 81 South Africa organoids and spheroids market, by application, 2018 - 2030 (USD Million)
Table 82 Saudi Arabia organoids and spheroids market, by type, 2018 - 2030 (USD Million)
Table 83 Saudi Arabia organoids and spheroids market, by end-use, 2018 - 2030 (USD Million)
Table 84 Saudi Arabia organoids and spheroids market, by application, 2018 - 2030 (USD Million)
Table 85 UAE organoids and spheroids market, by type, 2018 - 2030 (USD Million)
Table 86 UAE organoids and spheroids market, by end-use, 2018 - 2030 (USD Million)
Table 87 UAE organoids and spheroids market, by application, 2018 - 2030 (USD Million)
Table 88 Kuwait organoids and spheroids market, by type, 2018 - 2030 (USD Million)
Table 89 Kuwait organoids and spheroids market, by end-use, 2018 - 2030 (USD Million)
Table 90 Kuwait organoids and spheroids market, by application, 2018 - 2030 (USD Million)
Table 2 North America organoids and spheroids market, by type, 2018 - 2030 (USD Million)
Table 3 North America organoids and spheroids market, by end-use, 2018 - 2030 (USD Million)
Table 4 North America organoids and spheroids market, by application, 2018 - 2030 (USD Million)
Table 5 North America organoids and spheroids market, by region, 2018 - 2030 (USD Million)
Table 6 U.S. organoids and spheroids market, by type, 2018 - 2030 (USD Million)
Table 7 U.S. organoids and spheroids market, by end-use, 2018 - 2030 (USD Million)
Table 8 U.S. organoids and spheroids market, by application, 2018 - 2030 (USD Million)
Table 9 Canada organoids and spheroids market, by type, 2018 - 2030 (USD Million)
Table 10 Canada organoids and spheroids market, by end-use, 2018 - 2030 (USD Million)
Table 11 Canada organoids and spheroids market, by application, 2018 - 2030 (USD Million)
Table 12 Europe organoids and spheroids market, by type, 2018 - 2030 (USD Million)
Table 13 Europe organoids and spheroids market, by end-use, 2018 - 2030 (USD Million)
Table 14 Europe organoids and spheroids market, by application, 2018 - 2030 (USD Million)
Table 15 Europe organoids and spheroids market, by region, 2018 - 2030 (USD Million)
Table 16 Germany organoids and spheroids market, by type, 2018 - 2030 (USD Million)
Table 17 Germany organoids and spheroids market, by end-use, 2018 - 2030 (USD Million)
Table 18 Germany organoids and spheroids market, by application, 2018 - 2030 (USD Million)
Table 19 UK organoids and spheroids market, by type, 2018 - 2030 (USD Million)
Table 20 UK organoids and spheroids market, by end-use, 2018 - 2030 (USD Million)
Table 21 UK organoids and spheroids market, by application, 2018 - 2030 (USD Million)
Table 22 France organoids and spheroids market, by type, 2018 - 2030 (USD Million)
Table 23 France organoids and spheroids market, by end-use, 2018 - 2030 (USD Million)
Table 24 France organoids and spheroids market, by application, 2018 - 2030 (USD Million)
Table 25 Italy organoids and spheroids market, by type, 2018 - 2030 (USD Million)
Table 26 Italy organoids and spheroids market, by end-use, 2018 - 2030 (USD Million)
Table 27 Italy organoids and spheroids market, by application, 2018 - 2030 (USD Million)
Table 28 Spain organoids and spheroids market, by type, 2018 - 2030 (USD Million)
Table 29 Spain organoids and spheroids market, by end-use, 2018 - 2030 (USD Million)
Table 30 Spain organoids and spheroids market, by application, 2018 - 2030 (USD Million)
Table 31 Sweden organoids and spheroids market, by type, 2018 - 2030 (USD Million)
Table 32 Sweden organoids and spheroids market, by end-use, 2018 - 2030 (USD Million)
Table 33 Sweden organoids and spheroids market, by application, 2018 - 2030 (USD Million)
Table 34 Norway organoids and spheroids market, by type, 2018 - 2030 (USD Million)
Table 35 Norway organoids and spheroids market, by end-use, 2018 - 2030 (USD Million)
Table 36 Norway organoids and spheroids market, by application, 2018 - 2030 (USD Million)
Table 37 Denmark organoids and spheroids market, by type, 2018 - 2030 (USD Million)
Table 38 Denmark organoids and spheroids market, by end-use, 2018 - 2030 (USD Million)
Table 39 Denmark organoids and spheroids market, by application, 2018 - 2030 (USD Million)
Table 40 APAC organoids and spheroids market, by type, 2018 - 2030 (USD Million)
Table 41 APAC organoids and spheroids market, by end-use, 2018 - 2030 (USD Million)
Table 42 APAC organoids and spheroids market, by application, 2018 - 2030 (USD Million)
Table 43 APAC organoids and spheroids market, by region, 2018 - 2030 (USD Million)
Table 44 China organoids and spheroids market, by type, 2018 - 2030 (USD Million)
Table 45 China organoids and spheroids market, by end-use, 2018 - 2030 (USD Million)
Table 46 China organoids and spheroids market, by application, 2018 - 2030 (USD Million)
Table 47 Japan organoids and spheroids market, by type, 2018 - 2030 (USD Million)
Table 48 Japan organoids and spheroids market, by end-use, 2018 - 2030 (USD Million)
Table 49 Japan organoids and spheroids market, by application, 2018 - 2030 (USD Million)
Table 50 India organoids and spheroids market, by type, 2018 - 2030 (USD Million)
Table 51 India organoids and spheroids market, by end-use, 2018 - 2030 (USD Million)
Table 52 India organoids and spheroids market, by application, 2018 - 2030 (USD Million)
Table 53 Thailand organoids and spheroids market, by type, 2018 - 2030 (USD Million)
Table 54 Thailand organoids and spheroids market, by end-use, 2018 - 2030 (USD Million)
Table 55 Thailand organoids and spheroids market, by application, 2018 - 2030 (USD Million)
Table 56 South Korea organoids and spheroids market, by type, 2018 - 2030 (USD Million)
Table 57 South Korea organoids and spheroids market, by end-use, 2018 - 2030 (USD Million)
Table 58 South Korea organoids and spheroids market, by application, 2018 - 2030 (USD Million)
Table 59 Australia organoids and spheroids market, by type, 2018 - 2030 (USD Million)
Table 60 Australia organoids and spheroids market, by end-use, 2018 - 2030 (USD Million)
Table 61 Australia organoids and spheroids market, by application, 2018 - 2030 (USD Million)
Table 62 Latin America organoids and spheroids market, by type, 2018 - 2030 (USD Million)
Table 63 Latin America organoids and spheroids market, by end-use, 2018 - 2030 (USD Million)
Table 64 Latin America organoids and spheroids market, by application, 2018 - 2030 (USD Million)
Table 65 Latin America organoids and spheroids market, by region, 2018 - 2030 (USD Million)
Table 66 Brazil organoids and spheroids market, by type, 2018 - 2030 (USD Million)
Table 67 Brazil organoids and spheroids market, by end-use, 2018 - 2030 (USD Million)
Table 68 Brazil organoids and spheroids market, by application, 2018 - 2030 (USD Million)
Table 69 Mexico organoids and spheroids market, by type, 2018 - 2030 (USD Million)
Table 70 Mexico organoids and spheroids market, by end-use, 2018 - 2030 (USD Million)
Table 71 Mexico organoids and spheroids market, by application, 2018 - 2030 (USD Million)
Table 72 Argentina organoids and spheroids market, by type, 2018 - 2030 (USD Million)
Table 73 Argentina organoids and spheroids market, by end-use, 2018 - 2030 (USD Million)
Table 74 Argentina organoids and spheroids market, by application, 2018 - 2030 (USD Million)
Table 75 Middle East and Africa organoids and spheroids market, by type, 2018 - 2030 (USD Million)
Table 76 Middle East and Africa organoids and spheroids market, by end-use, 2018 - 2030 (USD Million)
Table 77 Middle East and Africa organoids and spheroids market, by application, 2018 - 2030 (USD Million)
Table 78 Middle East and Africa organoids and spheroids market, by region, 2018 - 2030 (USD Million)
Table 79 South Africa organoids and spheroids market, by type, 2018 - 2030 (USD Million)
Table 80 South Africa organoids and spheroids market, by end-use, 2018 - 2030 (USD Million)
Table 81 South Africa organoids and spheroids market, by application, 2018 - 2030 (USD Million)
Table 82 Saudi Arabia organoids and spheroids market, by type, 2018 - 2030 (USD Million)
Table 83 Saudi Arabia organoids and spheroids market, by end-use, 2018 - 2030 (USD Million)
Table 84 Saudi Arabia organoids and spheroids market, by application, 2018 - 2030 (USD Million)
Table 85 UAE organoids and spheroids market, by type, 2018 - 2030 (USD Million)
Table 86 UAE organoids and spheroids market, by end-use, 2018 - 2030 (USD Million)
Table 87 UAE organoids and spheroids market, by application, 2018 - 2030 (USD Million)
Table 88 Kuwait organoids and spheroids market, by type, 2018 - 2030 (USD Million)
Table 89 Kuwait organoids and spheroids market, by end-use, 2018 - 2030 (USD Million)
Table 90 Kuwait organoids and spheroids market, by application, 2018 - 2030 (USD Million)
List of Figures
Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value-chain-based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 Organoids and Spheroids: market outlook
Fig. 9 Organoids and Spheroids competitive insights
Fig. 10 Parent market outlook
Fig. 11 Related/ancillary market outlook
Fig. 12 Organoids and Spheroids market driver impact
Fig. 13 Organoids and Spheroids market restraint impact
Fig. 14 Organoids and Spheroids market strategic initiatives analysis
Fig. 15 Organoids and Spheroids market: type movement analysis
Fig. 16 Organoids and Spheroids market: type outlook and key takeaways
Fig. 17 Neural organoids market estimates and forecast, 2018 - 2030
Fig. 18 Hepatic organoids market estimates and forecast, 2018 - 2030
Fig. 19 Intestinal organoids market estimates and forecast, 2018 - 2030
Fig. 20 Other organoids market estimates and forecast, 2018 - 2030
Fig. 21 General submerged method for organoid culture market estimates and forecast, 2018 - 2030
Fig. 22 Crypt organoid culture techniques market estimates and forecast, 2018 - 2030
Fig. 23 ALI method for organoid culture market estimates and forecast, 2018 - 2030
Fig. 24 Clonal Organoids from Lgr5+ Cells market estimates and forecast, 2018 - 2030
Fig. 25 Brain and Retina Organoid Formation Protocol market estimates and forecast, 2018 - 2030
Fig. 26 Others Organoid Formation Protocol market estimates and forecast, 2018 - 2030
Fig. 27 Primary tissues market estimates and forecast, 2018 - 2030
Fig. 28 Stem cells market estimates and forecast, 2018 - 2030
Fig. 29 Spheroids market estimates and forecast, 2018 - 2030
Fig. 30 MCTS market estimates and forecast, 2018 - 2030
Fig. 31 Neurospheres market estimates and forecast, 2018 - 2030
Fig. 32 Mammospheres market estimates and forecast, 2018 - 2030
Fig. 33 Hepatospheres market estimates and forecast, 2018 - 2030
Fig. 34 Embryoid bodies market estimates and forecast, 2018 - 2030
Fig. 35 Micropatterned plates market estimates and forecast, 2018 - 2030
Fig. 36 Low cell attachment plates market estimates and forecast, 2018 - 2030
Fig. 37 Hanging drop method for spheroid culture market estimates and forecast, 2018 - 2030
Fig. 38 Other methods for spheroid culture market estimates and forecast, 2018 - 2030
Fig. 39 Cell line market estimates and forecast, 2018 - 2030
Fig. 40 Primary cell market estimates and forecast, 2018 - 2030
Fig. 41 iPSCs derived cells market estimates and forecast, 2018 - 2030
Fig. 42 Organoids and spheroids market: end-use movement analysis
Fig. 43 Organoids and spheroids market: end-use outlook and key takeaways
Fig. 44 Biotechnology and pharmaceutical industries market estimates and forecast, 2018 - 2030
Fig. 45 Academic & research institutes market estimates and forecast, 2018 - 2030
Fig. 46 Hospitals and diagnostic centers market estimates and forecast, 2018 - 2030
Fig. 47 Organoids and spheroids market: application movement analysis
Fig. 48 Organoids and spheroids market: application outlook and key takeaways
Fig. 49 Developmental biology market estimates and forecast, 2018 - 2030
Fig. 50 Personalized medicine market estimates and forecast, 2018 - 2030
Fig. 51 Regenerative medicine market estimates and forecast, 2018 - 2030
Fig. 52 Disease pathology studies market estimates and forecast, 2018 - 2030
Fig. 53 Drug toxicity & efficacy testing market estimates and forecast, 2018 - 2030
Fig. 54 Global Organoids and spheroids market: regional movement analysis
Fig. 55 Global Organoids and spheroids market: regional outlook and key takeaways
Fig. 56 North America
Fig. 57 North America market estimates and forecast, 2018 - 2030
Fig. 58 U.S. key country dynamics
Fig. 59 U.S. market estimates and forecast, 2018 - 2030
Fig. 60 Canada key country dynamics
Fig. 61 Canada market estimates and forecast, 2018 - 2030
Fig. 62 Europe
Fig. 63 Europe. market estimates and forecast, 2018 - 2030
Fig. 64 UK key country dynamics
Fig. 65 UK market estimates and forecast, 2018 - 2030
Fig. 66 Germany key country dynamics
Fig. 67 Germany market estimates and forecast, 2018 - 2030
Fig. 68 France key country dynamics
Fig. 69 France market estimates and forecast, 2018 - 2030
Fig. 70 Italy key country dynamics
Fig. 71 Italy market estimates and forecast, 2018 - 2030
Fig. 72 Spain key country dynamics
Fig. 73 Spain market estimates and forecast, 2018 - 2030
Fig. 74 Sweden key country dynamics
Fig. 75 Sweden market estimates and forecast, 2018 - 2030
Fig. 76 Norway key country dynamics
Fig. 77 Norway market estimates and forecast, 2018 - 2030
Fig. 78 Denmark key country dynamics
Fig. 79 Denmark market estimates and forecast, 2018 - 2030
Fig. 80 Asia Pacific
Fig. 81 Asia Pacific market estimates and forecast, 2018 - 2030
Fig. 82 China key country dynamics
Fig. 83 China market estimates and forecast, 2018 - 2030
Fig. 84 Japan key country dynamics
Fig. 85 Japan market estimates and forecast, 2018 - 2030
Fig. 86 India key country dynamics
Fig. 87 India market estimates and forecast, 2018 - 2030
Fig. 88 Australia key country dynamics
Fig. 89 Australia market estimates and forecast, 2018 - 2030
Fig. 90 Thailand key country dynamics
Fig. 91 Thailand market estimates and forecast, 2018 - 2030
Fig. 92 South Korea key country dynamics
Fig. 93 South Korea market estimates and forecast, 2018 - 2030
Fig. 94 Latin America
Fig. 95 Latin America market estimates and forecast, 2018 - 2030
Fig. 96 Brazil key country dynamics
Fig. 97 Brazil market estimates and forecast, 2018 - 2030
Fig. 98 Mexico key country dynamics
Fig. 99 Mexico market estimates and forecast, 2018 - 2030
Fig. 100 Argentina key country dynamics
Fig. 101 Argentina market estimates and forecast, 2018 - 2030
Fig. 102 Middle East and Africa
Fig. 103 Middle East and Africa. market estimates and forecast, 2018 - 2030
Fig. 104 Saudi Arabia key country dynamics
Fig. 105 Saudi Arabia market estimates and forecast, 2018 - 2030
Fig. 106 South Africa key country dynamics
Fig. 107 South Africa market estimates and forecast, 2018 - 2030
Fig. 108 UAE key country dynamics
Fig. 109 UAE market estimates and forecast, 2018 - 2030
Fig. 110 Kuwait key country dynamics
Fig. 111 Kuwait market estimates and forecast, 2018 - 2030
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value-chain-based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 Organoids and Spheroids: market outlook
Fig. 9 Organoids and Spheroids competitive insights
Fig. 10 Parent market outlook
Fig. 11 Related/ancillary market outlook
Fig. 12 Organoids and Spheroids market driver impact
Fig. 13 Organoids and Spheroids market restraint impact
Fig. 14 Organoids and Spheroids market strategic initiatives analysis
Fig. 15 Organoids and Spheroids market: type movement analysis
Fig. 16 Organoids and Spheroids market: type outlook and key takeaways
Fig. 17 Neural organoids market estimates and forecast, 2018 - 2030
Fig. 18 Hepatic organoids market estimates and forecast, 2018 - 2030
Fig. 19 Intestinal organoids market estimates and forecast, 2018 - 2030
Fig. 20 Other organoids market estimates and forecast, 2018 - 2030
Fig. 21 General submerged method for organoid culture market estimates and forecast, 2018 - 2030
Fig. 22 Crypt organoid culture techniques market estimates and forecast, 2018 - 2030
Fig. 23 ALI method for organoid culture market estimates and forecast, 2018 - 2030
Fig. 24 Clonal Organoids from Lgr5+ Cells market estimates and forecast, 2018 - 2030
Fig. 25 Brain and Retina Organoid Formation Protocol market estimates and forecast, 2018 - 2030
Fig. 26 Others Organoid Formation Protocol market estimates and forecast, 2018 - 2030
Fig. 27 Primary tissues market estimates and forecast, 2018 - 2030
Fig. 28 Stem cells market estimates and forecast, 2018 - 2030
Fig. 29 Spheroids market estimates and forecast, 2018 - 2030
Fig. 30 MCTS market estimates and forecast, 2018 - 2030
Fig. 31 Neurospheres market estimates and forecast, 2018 - 2030
Fig. 32 Mammospheres market estimates and forecast, 2018 - 2030
Fig. 33 Hepatospheres market estimates and forecast, 2018 - 2030
Fig. 34 Embryoid bodies market estimates and forecast, 2018 - 2030
Fig. 35 Micropatterned plates market estimates and forecast, 2018 - 2030
Fig. 36 Low cell attachment plates market estimates and forecast, 2018 - 2030
Fig. 37 Hanging drop method for spheroid culture market estimates and forecast, 2018 - 2030
Fig. 38 Other methods for spheroid culture market estimates and forecast, 2018 - 2030
Fig. 39 Cell line market estimates and forecast, 2018 - 2030
Fig. 40 Primary cell market estimates and forecast, 2018 - 2030
Fig. 41 iPSCs derived cells market estimates and forecast, 2018 - 2030
Fig. 42 Organoids and spheroids market: end-use movement analysis
Fig. 43 Organoids and spheroids market: end-use outlook and key takeaways
Fig. 44 Biotechnology and pharmaceutical industries market estimates and forecast, 2018 - 2030
Fig. 45 Academic & research institutes market estimates and forecast, 2018 - 2030
Fig. 46 Hospitals and diagnostic centers market estimates and forecast, 2018 - 2030
Fig. 47 Organoids and spheroids market: application movement analysis
Fig. 48 Organoids and spheroids market: application outlook and key takeaways
Fig. 49 Developmental biology market estimates and forecast, 2018 - 2030
Fig. 50 Personalized medicine market estimates and forecast, 2018 - 2030
Fig. 51 Regenerative medicine market estimates and forecast, 2018 - 2030
Fig. 52 Disease pathology studies market estimates and forecast, 2018 - 2030
Fig. 53 Drug toxicity & efficacy testing market estimates and forecast, 2018 - 2030
Fig. 54 Global Organoids and spheroids market: regional movement analysis
Fig. 55 Global Organoids and spheroids market: regional outlook and key takeaways
Fig. 56 North America
Fig. 57 North America market estimates and forecast, 2018 - 2030
Fig. 58 U.S. key country dynamics
Fig. 59 U.S. market estimates and forecast, 2018 - 2030
Fig. 60 Canada key country dynamics
Fig. 61 Canada market estimates and forecast, 2018 - 2030
Fig. 62 Europe
Fig. 63 Europe. market estimates and forecast, 2018 - 2030
Fig. 64 UK key country dynamics
Fig. 65 UK market estimates and forecast, 2018 - 2030
Fig. 66 Germany key country dynamics
Fig. 67 Germany market estimates and forecast, 2018 - 2030
Fig. 68 France key country dynamics
Fig. 69 France market estimates and forecast, 2018 - 2030
Fig. 70 Italy key country dynamics
Fig. 71 Italy market estimates and forecast, 2018 - 2030
Fig. 72 Spain key country dynamics
Fig. 73 Spain market estimates and forecast, 2018 - 2030
Fig. 74 Sweden key country dynamics
Fig. 75 Sweden market estimates and forecast, 2018 - 2030
Fig. 76 Norway key country dynamics
Fig. 77 Norway market estimates and forecast, 2018 - 2030
Fig. 78 Denmark key country dynamics
Fig. 79 Denmark market estimates and forecast, 2018 - 2030
Fig. 80 Asia Pacific
Fig. 81 Asia Pacific market estimates and forecast, 2018 - 2030
Fig. 82 China key country dynamics
Fig. 83 China market estimates and forecast, 2018 - 2030
Fig. 84 Japan key country dynamics
Fig. 85 Japan market estimates and forecast, 2018 - 2030
Fig. 86 India key country dynamics
Fig. 87 India market estimates and forecast, 2018 - 2030
Fig. 88 Australia key country dynamics
Fig. 89 Australia market estimates and forecast, 2018 - 2030
Fig. 90 Thailand key country dynamics
Fig. 91 Thailand market estimates and forecast, 2018 - 2030
Fig. 92 South Korea key country dynamics
Fig. 93 South Korea market estimates and forecast, 2018 - 2030
Fig. 94 Latin America
Fig. 95 Latin America market estimates and forecast, 2018 - 2030
Fig. 96 Brazil key country dynamics
Fig. 97 Brazil market estimates and forecast, 2018 - 2030
Fig. 98 Mexico key country dynamics
Fig. 99 Mexico market estimates and forecast, 2018 - 2030
Fig. 100 Argentina key country dynamics
Fig. 101 Argentina market estimates and forecast, 2018 - 2030
Fig. 102 Middle East and Africa
Fig. 103 Middle East and Africa. market estimates and forecast, 2018 - 2030
Fig. 104 Saudi Arabia key country dynamics
Fig. 105 Saudi Arabia market estimates and forecast, 2018 - 2030
Fig. 106 South Africa key country dynamics
Fig. 107 South Africa market estimates and forecast, 2018 - 2030
Fig. 108 UAE key country dynamics
Fig. 109 UAE market estimates and forecast, 2018 - 2030
Fig. 110 Kuwait key country dynamics
Fig. 111 Kuwait market estimates and forecast, 2018 - 2030
Companies Mentioned
- Thermo Fisher Scientific, Inc.
- Merck KGaA
- Lonza
- 3D Biomatrix
- 3D Biotek LLC
- AMS Biotechnology (Europe) Limited
- Cellesce Ltd
- Corning Incorporated
- Greiner Bio-One
- Hubrecht Organoid Technology (HUB)
- InSphero
- Prellis Biologics
- STEMCELL Technologies Inc.
Methodology
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 120 |
| Published | February 2024 |
| Forecast Period | 2023 - 2030 |
| Estimated Market Value ( USD | $ 780.7 Million |
| Forecasted Market Value ( USD | $ 3260 Million |
| Compound Annual Growth Rate | 23.1% |
| Regions Covered | Global |
| No. of Companies Mentioned | 13 |
